To study the independent effects of each gene, overexpression of CRYβB2 and CRYβB2P1 and CRISPR knockout of CRYβB2P1 cell models from three triple-negative breast cancer (TNBC) cell lines were established (Fig. 2). This evidence concerns the gene CRYBB2 and triple-negative breast carcinoma.